| Development of a core evaluation framework of value-added medicines: report 1 on methodology and findings ZI Petykó, Z Kaló, J Espin, K Podrazilová, T Tesař, N Maniadakis, ... Cost Effectiveness and Resource Allocation 19 (1), 57, 2021 | 8 | 2021 |
| Development of a core evaluation framework of value-added medicines: report 2 on pharmaceutical policy perspectives Z Kaló, ZI Petykó, FU Fricke, N Maniadakis, T Tesař, K Podrazilová, ... Cost Effectiveness and Resource Allocation 19, 1-8, 2021 | 7 | 2021 |
| Barriers and facilitators of exploiting the potential of value-added medicines ZI Petyko, A Inotai, AP Holtorf, D Brixner, Z Kaló Expert Review of Pharmacoeconomics & Outcomes Research 20 (3), 229-236, 2020 | 7 | 2020 |
| Recommendations to overcome barriers to the use of artificial intelligence-driven evidence in health technology assessment A Zemplényi, K Tachkov, L Balkanyi, B Németh, ZI Petykó, G Petrova, ... Frontiers in Public Health 11, 1088121, 2023 | 6 | 2023 |
| Recommendations for patient involvement in health technology assessment in Central and Eastern European countries I Jakab, M Dimitrova, F Houÿez, T Bereczky, M Fövényes, Z Maravic, ... Frontiers in public health 11, 1176200, 2023 | 2 | 2023 |
| Guidance on using real-world evidence from Western Europe in Central and Eastern European health policy decision making B Németh, M Kamusheva, Z Mitkova, ZI Petykó, A Zemplényi, M Dimitrova, ... Journal of Comparative Effectiveness Research 12 (4), e220157, 2023 | 2 | 2023 |
| Effectiveness of educational interventions for healthcare workers on vaccination dialogue with older adults: a systematic review MD Wennekes, T Almási, R Eilers, F Mezei, ZI Petykó, A Timen, Z Vokó, ... Archives of Public Health 82 (1), 34, 2024 | 1 | 2024 |
| Characteristics of effective educational interventions targeting healthcare workers to improve advising about vaccinations for older adults: a systematic review M Wennekes, T Almási, R Eilers, F Mezei, Z Petykó, A Timen, Z Vokó Population Medicine 5 (Supplement), 2023 | 1 | 2023 |
| Protocol for the development of an artificial intelligence extension to the Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 C Hawksworth, J Elvidge, S Knies, A Zemplenyi, Z Petyko, P Siirtola, ... medRxiv, 2023.05. 31.23290788, 2023 | 1 | 2023 |
| Correction: Effectiveness of educational interventions for healthcare workers on vaccination dialogue with older adults: a systematic review MD Wennekes, T Almási, R Eilers, F Mezei, ZI Petykó, A Timen, Z Vokó, ... Archives of Public Health 82, 2024 | | 2024 |
| Systematic literature review on biomarkers associated with metabolic decompensation events in propionic acidemia K Gyongyosi, T Zelei, Z Petyko, Z Voko, V Sikirica HUMAN GENE THERAPY 33 (23-24), A174-A174, 2022 | | 2022 |
| HPR95 Opportunities and Challenges for Value Added Medicines: Results of a Scoping Research Based on Expert Interviews Z Petykó, A Inotai, J Espin, DT O’Keeffe, JF O'Mahony, M Czech, Z Kalo Value in Health 25 (12), S249, 2022 | | 2022 |
| PNS108 Proposal for a Core Evaluation Framework of Value Added Medicines Z Petykó, Z Kaló, J Espin, FU Fricke, NS Hawkins, N Maniadakis, ... Value in Health 23, S659-S660, 2020 | | 2020 |
| PDG10 IMPROVING THE BUSINESS MODEL OF VALUE ADDED MEDICINES: NEW VALUE ASSESSMENT FRAMEWORK IS NEEDED Z Petykó, A Inotai, Z Kalo Value in Health 22, S598, 2019 | | 2019 |
| Survival of Propionic Acidemia Patients with Liver Transplant T Zelei, Z Vokó, B Németh, Z Petykó, G Banerjee, V Sikirica Available at SSRN 4793610, 0 | | |
